Free Trial
NYSE:AVNS

Avanos Medical (AVNS) Stock Price, News & Analysis

Avanos Medical logo
$24.96 -0.03 (-0.10%)
As of 09:52 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Avanos Medical Stock (NYSE:AVNS)

Advanced

Key Stats

Today's Range
$24.96
$24.99
50-Day Range
$13.69
$25.09
52-Week Range
$9.30
$25.49
Volume
5,118 shs
Average Volume
1.11 million shs
Market Capitalization
$1.17 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Avanos Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

AVNS MarketRank™: 

Avanos Medical scored higher than 7% of companies evaluated by MarketBeat, and ranked 845th out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avanos Medical has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Avanos Medical has only been the subject of 2 research reports in the past 90 days.

  • Read more about Avanos Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Avanos Medical are expected to decrease by -11.32% in the coming year, from $1.06 to $0.94 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avanos Medical is -15.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avanos Medical is -15.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avanos Medical has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Avanos Medical's valuation and earnings.
  • Percentage of Shares Shorted

    2.54% of the float of Avanos Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avanos Medical has a short interest ratio ("days to cover") of 0.97, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Avanos Medical has recently increased by 1.34%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Avanos Medical does not currently pay a dividend.

  • Dividend Growth

    Avanos Medical does not have a long track record of dividend growth.

    • Insider Buying vs. Insider Selling

      In the past three months, Avanos Medical insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      2.33% of the stock of Avanos Medical is held by insiders.

    • Percentage Held by Institutions

      95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about Avanos Medical's insider trading history.
    Receive AVNS Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

    SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    AVNS Stock News Headlines

    SpaceX will mint billionaires. You won't be one of them.
    By the time a company goes public, 95% of the profits are typically already gone. SpaceX insiders bought in at a $20 billion valuation - you're being offered entry at $1.75 trillion. But one small, publicly traded company sits directly in SpaceX's supply chain, still priced like Wall Street hasn't noticed. It powers critical infrastructure Musk's operation can't run without. Dylan Jovine is naming it today, free.tc pixel
    Summers Value Partners Q1 2026 Partner Letter
    See More Headlines

    AVNS Stock Analysis - Frequently Asked Questions

    Avanos Medical's stock was trading at $11.23 at the start of the year. Since then, AVNS shares have increased by 122.3% and is now trading at $24.9650.

    Avanos Medical, Inc. (NYSE:AVNS) posted its quarterly earnings data on Tuesday, May, 5th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.06. The company's revenue for the quarter was up 8.8% compared to the same quarter last year.

    Top institutional shareholders of Avanos Medical include Dimensional Fund Advisors LP (4.41%), Punch & Associates Investment Management Inc. (0.93%), Bank of New York Mellon Corp (0.66%) and Principal Financial Group Inc. (0.62%). Insiders that own company stock include Michael Greiner, Gary Blackford, Kerr Holbrook and Julie Ann Shimer.
    View institutional ownership trends
    .

    Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA).

    Company Calendar

    Last Earnings
    5/05/2026
    Today
    6/15/2026
    Next Earnings (Estimated)
    8/04/2026
    Fiscal Year End
    12/31/2026

    Industry, Sector and Symbol

    Stock Exchange
    NYSE
    Sector
    Medical
    Industry
    MED INSTRUMENTS
    Sub-Industry
    Medical Equipment
    Current Symbol
    NYSE:AVNS
    CIK
    1606498
    Fax
    N/A
    Employees
    2,287
    Year Founded
    2014

    Profitability

    EPS (Trailing Twelve Months)
    ($1.61)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    23.54
    P/E Growth
    N/A
    Net Income
    -$72.90 million
    Net Margins
    -10.39%
    Pretax Margin
    -9.54%
    Return on Equity
    5.39%
    Return on Assets
    3.97%

    Debt

    Debt-to-Equity Ratio
    0.11
    Current Ratio
    2.48
    Quick Ratio
    1.40

    Sales & Book Value

    Annual Sales
    $701.20 million
    Price / Sales
    1.67
    Cash Flow
    $3.42 per share
    Price / Cash Flow
    7.29
    Book Value
    $16.73 per share
    Price / Book
    1.49

    Miscellaneous

    Outstanding Shares
    46,850,000
    Free Float
    45,756,000
    Market Cap
    $1.17 billion
    Optionable
    Optionable
    Beta
    1.56

    Social Links

    Don't Wait for the OpenAI IPO Cover

    The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

    Get This Free Report

    This page (NYSE:AVNS) was last updated on 6/15/2026 by MarketBeat.com Staff.
    From Our Partners